256 related articles for article (PubMed ID: 16153529)
1. Hydroxychloroquine-induced cardiotoxicity in a 39-year-old woman with systemic lupus erythematosus and systolic dysfunction.
Keating RJ; Bhatia S; Amin S; Williams A; Sinak LJ; Edwards WD
J Am Soc Echocardiogr; 2005 Sep; 18(9):981. PubMed ID: 16153529
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine: a treatable cause of cardiomyopathy.
Abbasi S; Tarter L; Farzaneh-Far R; Farzaneh-Far A
J Am Coll Cardiol; 2012 Aug; 60(8):786. PubMed ID: 22898072
[No Abstract] [Full Text] [Related]
3. New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy--a report of 2 cases.
Soong TR; Barouch LA; Champion HC; Wigley FM; Halushka MK
Hum Pathol; 2007 Dec; 38(12):1858-63. PubMed ID: 18061791
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy.
Ratliff NB; Estes ML; Myles JL; Shirey EK; McMahon JT
N Engl J Med; 1987 Jan; 316(4):191-3. PubMed ID: 3796692
[No Abstract] [Full Text] [Related]
5. Hydroxychloroquine-induced cardiomyopathy that presented as pulmonary hypertension: a newly noted complication.
Bae SM; Jung HO; Ihm SM; Kim JJ; Chin JY; Kim TS; Park SH; Youn HJ; Lee KY
Cardiology; 2012; 123(3):197-200. PubMed ID: 23154245
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine myopathy.
Richards AJ
J Rheumatol; 1998 Aug; 25(8):1642-3. PubMed ID: 9712114
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine-induced cardiomyopathy: a case report.
Muthukrishnan P; Roukoz H; Grafton G; Jessurun J; Colvin-Adams M
Circ Heart Fail; 2011 Mar; 4(2):e7-8. PubMed ID: 21406675
[No Abstract] [Full Text] [Related]
8. [Toxic hydroxychloroquine-induced cardiomyopathy complicating systemic lupus treatment].
Bories MC; Gibault L; Tharaux PL; Bruneval P
Ann Pathol; 2021 Feb; 41(1):101-104. PubMed ID: 33419598
[TBL] [Abstract][Full Text] [Related]
9. [Proximal myopathy and fulminant heart failure in a 57 year-old female patient with lupus erythematosus].
Wille F; Birkmeier S; Tiemann K; Lewalter T; Klingel K; Rabe C; Sick P
Internist (Berl); 2020 Aug; 61(8):854-859. PubMed ID: 32504300
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature.
Nord JE; Shah PK; Rinaldi RZ; Weisman MH
Semin Arthritis Rheum; 2004 Apr; 33(5):336-51. PubMed ID: 15079764
[TBL] [Abstract][Full Text] [Related]
11. Fatal antimalarial-induced cardiomyopathy: report of 2 cases.
Azimian M; Gultekin SH; Hata JL; Atkinson JB; Ely KA; Fuchs HA; Mobley BC
J Clin Rheumatol; 2012 Oct; 18(7):363-6. PubMed ID: 23047537
[TBL] [Abstract][Full Text] [Related]
12. Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment.
Yogasundaram H; Putko BN; Tien J; Paterson DI; Cujec B; Ringrose J; Oudit GY
Can J Cardiol; 2014 Dec; 30(12):1706-15. PubMed ID: 25475472
[TBL] [Abstract][Full Text] [Related]
13. Maculopathy in patient with systemic lupus erythematosus treated with hydroxychloroquine.
Rodríguez-Hurtado FJ; Sáez-Moreno JA; Rodríguez-Ferrer JM
Reumatol Clin; 2012; 8(5):280-3. PubMed ID: 22481059
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine-induced phospholipidosis in a case of SLE: the wolf in zebra clothing.
Khubchandani SR; Bichle LS
Ultrastruct Pathol; 2013 Apr; 37(2):146-50. PubMed ID: 23573895
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus.
Reynaert S; Setterfield J; Black MM
J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):487-8. PubMed ID: 16643169
[No Abstract] [Full Text] [Related]
16. Left Ventricular noncompaction in a patient with systemic lupus erythematosus.
Dobranici M; Tocitu A; Delcea C; Dan GA
Rom J Intern Med; 2019 Mar; 57(1):78-82. PubMed ID: 30379642
[TBL] [Abstract][Full Text] [Related]
17. [Chloroquine cardiotoxicity in long-term lupus therapy in two patients].
Saussine A; Loriot MA; Picard C; Lecerf V; Landry J; Scheer I; Voicu S; Leenhardt A; Ducrocq G; Maubec E; Crickx B
Ann Dermatol Venereol; 2009; 136(6-7):530-5. PubMed ID: 19560616
[TBL] [Abstract][Full Text] [Related]
18. Heart Involvement in a Woman Treated with Hydroxychloroquine for Systemic Lupus Erythematosus Revealing Fabry Disease.
Chatre C; Filippi N; Roubille F; Pers YM
J Rheumatol; 2016 May; 43(5):997-8. PubMed ID: 27134281
[No Abstract] [Full Text] [Related]
19. Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases.
Costedoat-Chalumeau N; Hulot JS; Amoura Z; Leroux G; Lechat P; Funck-Brentano C; Piette JC
Rheumatology (Oxford); 2007 May; 46(5):808-10. PubMed ID: 17202178
[TBL] [Abstract][Full Text] [Related]
20. Evidence for risk of cardiomyopathy with hydroxychloroquine.
Sumpter MD; Tatro LS; Stoecker WV; Rader RK
Lupus; 2012 Dec; 21(14):1594-6. PubMed ID: 23036986
[No Abstract] [Full Text] [Related]
[Next] [New Search]